Literature DB >> 28188318

PURLs: Need an add-on to metformin? Consider this.

David Wyncott1, Corey Lyon2, Anne Mounsey3.   

Abstract

Sulfonylureas have been the preferred add-on therapy to metformin for T2DM, but a study finds that DPP-4s have lower risks of death, CV events, and hypoglycemia.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28188318      PMCID： PMC5329113     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  11 in total

1.  CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.

Authors:  Alan J Garber; Martin J Abrahamson; Joshua I Barzilay; Lawrence Blonde; Zachary T Bloomgarden; Michael A Bush; Samuel Dagogo-Jack; Ralph A DeFronzo; Daniel Einhorn; Vivian A Fonseca; Jeffrey R Garber; W Timothy Garvey; George Grunberger; Yehuda Handelsman; Robert R Henry; Irl B Hirsch; Paul S Jellinger; Janet B McGill; Jeffrey I Mechanick; Paul D Rosenblit; Guillermo E Umpierrez
Journal:  Endocr Pract       Date:  2016-01       Impact factor: 3.443

2.  Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Authors:  Benjamin M Scirica; Deepak L Bhatt; Eugene Braunwald; P Gabriel Steg; Jaime Davidson; Boaz Hirshberg; Peter Ohman; Robert Frederich; Stephen D Wiviott; Elaine B Hoffman; Matthew A Cavender; Jacob A Udell; Nihar R Desai; Ofri Mosenzon; Darren K McGuire; Kausik K Ray; Lawrence A Leiter; Itamar Raz
Journal:  N Engl J Med       Date:  2013-09-02       Impact factor: 91.245

3.  A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin.

Authors:  Azim S Gangji; Tali Cukierman; Hertzel C Gerstein; Charles H Goldsmith; Catherine M Clase
Journal:  Diabetes Care       Date:  2007-02       Impact factor: 19.112

Review 4.  Diabetes in Asia: epidemiology, risk factors, and pathophysiology.

Authors:  Juliana C N Chan; Vasanti Malik; Weiping Jia; Takashi Kadowaki; Chittaranjan S Yajnik; Kun-Ho Yoon; Frank B Hu
Journal:  JAMA       Date:  2009-05-27       Impact factor: 56.272

5.  Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.

Authors:  Rodney A Hayward; Peter D Reaven; Wyndy L Wiitala; Gideon D Bahn; Domenic J Reda; Ling Ge; Madeline McCarren; William C Duckworth; Nicholas V Emanuele
Journal:  N Engl J Med       Date:  2015-06-04       Impact factor: 91.245

6.  2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial.

Authors:  Baptist Gallwitz; Julio Rosenstock; Thomas Rauch; Sudipta Bhattacharya; Sanjay Patel; Maximilian von Eynatten; Klaus A Dugi; Hans-Juergen Woerle
Journal:  Lancet       Date:  2012-06-28       Impact factor: 79.321

7.  Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.

Authors:  Shuo-Ming Ou; Chia-Jen Shih; Pei-Wen Chao; Hsi Chu; Shu-Chen Kuo; Yi-Jung Lee; Shuu-Jiun Wang; Chih-Yu Yang; Chih-Ching Lin; Tzeng-Ji Chen; Der-Cherng Tarng; Szu-Yuan Li; Yung-Tai Chen
Journal:  Ann Intern Med       Date:  2015-10-13       Impact factor: 25.391

8.  A Multicenter Observational Study of Incretin-based Drugs and Heart Failure.

Authors:  Kristian B Filion; Laurent Azoulay; Robert W Platt; Matthew Dahl; Colin R Dormuth; Kristin K Clemens; Nianping Hu; J Michael Paterson; Laura Targownik; Tanvir C Turin; Jacob A Udell; Pierre Ernst
Journal:  N Engl J Med       Date:  2016-03-24       Impact factor: 91.245

9.  Rationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE).

Authors:  David M Nathan; John B Buse; Steven E Kahn; Heidi Krause-Steinrauf; Mary E Larkin; Myrlene Staten; Deborah Wexler; John M Lachin
Journal:  Diabetes Care       Date:  2013-05-20       Impact factor: 19.112

10.  Response to Comment on American Diabetes Association. Approaches to Glycemic Treatment. Sec. 7. In Standards of Medical Care in Diabetes-2016. Diabetes Care 2016;39(Suppl. 1):S52-S59.

Authors:  William H Herman; Rita R Kalyani; Deborah J Wexler; David R Matthews; Silvio E Inzucchi
Journal:  Diabetes Care       Date:  2016-06       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.